John Lewicki

9.2k total citations · 3 hit papers
94 papers, 6.9k citations indexed

About

John Lewicki is a scholar working on Molecular Biology, Oncology and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, John Lewicki has authored 94 papers receiving a total of 6.9k indexed citations (citations by other indexed papers that have themselves been cited), including 56 papers in Molecular Biology, 34 papers in Oncology and 16 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in John Lewicki's work include Cancer Cells and Metastasis (19 papers), Heart Failure Treatment and Management (13 papers) and Receptor Mechanisms and Signaling (13 papers). John Lewicki is often cited by papers focused on Cancer Cells and Metastasis (19 papers), Heart Failure Treatment and Management (13 papers) and Receptor Mechanisms and Signaling (13 papers). John Lewicki collaborates with scholars based in United States, Australia and Iran. John Lewicki's co-authors include Robert M. Scarborough, Thomas Maack, Austin Gurney, Glenn McEnroe, Daniel R. Nussenzveig, Michael F. Clarke, Timothy Hoey, Dale B. Schenk, J G Porter and Xinhao Wang and has published in prestigious journals such as Nature, Science and New England Journal of Medicine.

In The Last Decade

John Lewicki

93 papers receiving 6.5k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Physiological Role of Silent Receptors of Atrial Natriuretic Factor

1987 786 citations Thomas Maack, Robert M. Scarborough et al. profile →
The Prognostic Role of a Gene Signature from Tumorigenic Breast-Cancer Cells

2007 742 citations Rui Liu, Xinhao Wang et al. New England Journal of Medicine profile →
Atrial natriuretic peptide clearance receptor. Complete sequence and functional expression of cDNA clones.

1988 412 citations Forrest Fuller, J G Porter et al. Journal of Biological Chemistry profile →

Peers

Countries citing papers authored by John Lewicki

Since Specialization

Citations

This map shows the geographic impact of John Lewicki's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by John Lewicki with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites John Lewicki more than expected).

Fields of papers citing papers by John Lewicki

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by John Lewicki. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by John Lewicki. The network helps show where John Lewicki may publish in the future.

Co-authorship network of co-authors of John Lewicki

This figure shows the co-authorship network connecting the top 25 collaborators of John Lewicki. A scholar is included among the top collaborators of John Lewicki based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with John Lewicki. John Lewicki is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Abstract 2003: Antibody against TIGIT (T cell immunoreceptor with Ig and ITIM domains) induces anti-tumor immune response and generates long-term immune memory 2017 ·Cancer Research ·(unknown), Minu K. Srivastava, Erin Mayes, (unknown), (unknown), Christopher L. Murriel, Ming-Hong Xie, Andrew Lam, May Ji, Fumiko Axelrod, (unknown), John Lewicki, Tim Hoey, Austin Gurney	8
2	WNT antagonists exhibit unique combinatorial antitumor activity with taxanes by potentiating mitotic cell death 2017 ·Science Advances ·Marcus Fischer, Belinda Cancilla, Vincent Yeung, Fiore Cattaruzza, Cécile Chartier, Christopher L. Murriel, Jennifer Cain, (unknown), Chieh-Yang Cheng, James Evans, Gilbert O’Young, Xiaomei Song, John Lewicki, Ann M. Kapoun, Austin Gurney, Wan-Ching Yen, Timothy Hoey	122
3	Targeting Notch Signaling with a Notch2/Notch3 Antagonist (Tarextumab) Inhibits Tumor Growth and Decreases Tumor-Initiating Cell Frequency 2015 ·Clinical Cancer Research ·Wan-Ching Yen, Marcus Fischer, Fumiko Axelrod, Christopher J. Bond, Jennifer Cain, Belinda Cancilla, (unknown), René Meisner, Aaron K. Sato, Jalpa Shah, Tracy Tang, Breanna Wallace, Min Wang, Chun Zhang, Ann M. Kapoun, John Lewicki, Austin Gurney, Timothy Hoey	195
4	Abstract 4367: Discovery and evaluation of pharmacodynamic and predictive biomarkers for anti-RSPO3, a treatment that reduces tumor growth and cancer stem cell frequency in patient derived xenograft tumor models 2015 ·Cancer Research ·Fiore Cattaruzza, (unknown), Wan-Ching Yen, Alayne Brunner, Min Wang, (unknown), Marcus Fischer, Gilbert O’Young, Cécile Chartier, Austin Gurney, Tim Hoey, John Lewicki, Ann M. Kapoun	1
5	Anti-DLL4 Has Broad Spectrum Activity in Pancreatic Cancer Dependent on Targeting DLL4-Notch Signaling in Both Tumor and Vasculature Cells 2012 ·Clinical Cancer Research ·(unknown), Marcus Fischer, Mark J. Hynes, Jingjiang Wu, Edward Kim, Lucia Beviglia, Vincent Yeung, Xiaomei Song, Ann M. Kapoun, John Lewicki, Austin Gurney, Diane M. Simeone, Timothy Hoey	58
6	Xenografts faithfully recapitulate breast cancer-specific gene expression patterns of parent primary breast tumors 2012 ·Breast Cancer Research and Treatment ·Laura A. Petrillo, Denise M. Wolf, Ann M. Kapoun, Nicholas J. Wang, Andrea J. Barczak, Yuanyuan Xiao, Hasan Körkaya, Frederick L. Baehner, John Lewicki, Max S. Wicha, John W. Park, Paul T. Spellman, Joe W. Gray, Laura van’t Veer, Laura J. Esserman	31
7	Anti-DLL4 Inhibits Growth and Reduces Tumor-Initiating Cell Frequency in Colorectal Tumors with Oncogenic KRAS Mutations 2010 ·Cancer Research ·Marcus Fischer, Wan-Ching Yen, Ann M. Kapoun, Min Wang, Gilbert O’Young, John Lewicki, Austin Gurney, Timothy Hoey	100
8	DLL4 Blockade Inhibits Tumor Growth and Reduces Tumor-Initiating Cell Frequency 2009 ·Cell stem cell ·Timothy Hoey, Wan-Ching Yen, Fumiko Axelrod, (unknown), (unknown), Scott J. Dylla, (unknown), Sasha Lazetic, Inkyung Park, Aaron K. Sato, Sanjeev Satyal, Xinhao Wang, Michael F. Clarke, John Lewicki, Austin Gurney	318
9	Colorectal Cancer Stem Cells Are Enriched in Xenogeneic Tumors Following Chemotherapy 2008 ·PLoS ONE ·Scott J. Dylla, Lucia Beviglia, In‐Kyung Park, Cécile Chartier, Janak Raval, (unknown), (unknown), Jorge Aguilar, Sasha Lazetic, Stephanie Smith‐Berdan, Michael F. Clarke, Tim Hoey, John Lewicki, Austin Gurney	448
10	Correction: Colorectal Cancer Stem Cells Are Enriched in Xenogeneic Tumors Following Chemotherapy 2008 ·PLoS ONE ·Scott J. Dylla, Lucia Beviglia, Inkyung Park, Cécile Chartier, Janak Raval, (unknown), (unknown), Jorge Aguilar, Sasha Lazetic, Stephanie Smith‐Berdan, Michael F. Clarke, Tim Hoey, John Lewicki, Austin Gurney	39
11	The Prognostic Role of a Gene Signature from Tumorigenic Breast-Cancer Cells breakdown → 2007 ·New England Journal of Medicine ·Rui Liu, Xinhao Wang, Grace Chen, Piero Dalerba, Austin Gurney, Timothy Hoey, Gavin Sherlock, John Lewicki, Kerby Shedden, Michael F. Clarke	742
12	Indole-based heterocyclic inhibitors of p38α MAP kinase: designing a conformationally restricted analogue 2003 ·Bioorganic & Medicinal Chemistry Letters ·Babu Mavunkel, Sarvajit Chakravarty, John Perumattam, Gregory R. Luedtke, Xi Liang, (unknown), Yongjin Xu, Maureen Laney, David Y. Liu, George F. Schreiner, John Lewicki, Sundeep Dugar	22
13	Lipid levels and peripheral vascular disease in diabetic and non-diabetic subjects 1998 ·Atherosclerosis ·DN O'Neal, John Lewicki, (unknown), P. G. Matthews, James D. Best	31
14	Effects of small C-ANF receptor ligands on plasma levels of atrial natriuretic factor, blood pressure, and renal function in the rat 1991 ·Canadian Journal of Physiology and Pharmacology ·J Okolicány, Glenn McEnroe, (unknown), John Lewicki, Thomas Maack	8
15	Hemodynamic Effects of Atrial Natriuretic Factor Clearance Receptor Occupancy in Conscious Sheep 1990 ·American Journal of Hypertension ·David G. Parkes, J. P. Coghlan, John Lewicki, Robert M. Scarborough, B. A. Scoggins	2
16	Isolation and functional expression of the human atrial natriuretic peptide clearance receptor cDNA 1990 ·Biochemical and Biophysical Research Communications ·J. Gordon Porter, Ann Arfsten, Forrest Fuller, Judith Miller, (unknown), John Lewicki	94
17	Human and canine gene homologs of porcine brain natriuretic peptide 1989 ·Biochemical and Biophysical Research Communications ·Jeffrey J. Seilhamer, Ann Arfsten, Judith Miller, (unknown), Robert M. Scarborough, John Lewicki, J G Porter	106
18	Monoclonal Antibodies to Surfactant Proteins SP28–36 Label Canine Type II and Nonciliated Bronchiolar Cells by Immunofluorescence 1988 ·American Review of Respiratory Disease ·Mary C. Williams, Samuel Hawgood, Dale B. Schenk, John Lewicki, (unknown), B J Benson	38
19	Cloning, sequence analysis, and processing of the rat and human atrial natriuretic peptide precursors. 1986 ·PubMed ·John Lewicki, Barry Greenberg, Miles K. Yamanaka, G P Vlasuk, Michael Brewer, David C. Gardner, John D. Baxter, (unknown), John C. Fiddes	20
20	Quantification of guanylate cyclase concentrations by a direct double determinant tandem immunoradiometric assay. 1983 ·Journal of Biological Chemistry ·John Lewicki, Bing Chang, Ferid Murad	11

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact